PROCEPT BioRobotics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade PROCEPT BioRobotics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PRCT
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH.
CEOLarry L. Wood
CEOLarry L. Wood
Employees756
Employees756
HeadquartersSan Jose, California
HeadquartersSan Jose, California
Founded2007
Founded2007
Employees756
Employees756
PRCT Key Statistics
Market cap1.83B
Market cap1.83B
Price-Earnings ratio-21.28
Price-Earnings ratio-21.28
Dividend yield—
Dividend yield—
Average volume1.49M
Average volume1.49M
High today$34.80
High today$34.80
Low today$32.38
Low today$32.38
Open price$34.30
Open price$34.30
Volume1.36M
Volume1.36M
52 Week high$89.49
52 Week high$89.49
52 Week low$27.80
52 Week low$27.80
Stock Snapshot
The current PROCEPT BioRobotics(PRCT) stock price is $32.73, with a market capitalization of 1.83B. The stock trades at a price-to-earnings (P/E) ratio of -21.28.
On 2025-12-19, PROCEPT BioRobotics(PRCT) stock traded between a low of $32.38 and a high of $34.80. Shares are currently priced at $32.73, which is +1.1% above the low and -5.9% below the high.
The PROCEPT BioRobotics(PRCT)'s current trading volume is 1.36M, compared to an average daily volume of 1.49M.
In the last year, PROCEPT BioRobotics(PRCT) shares hit a 52-week high of $89.49 and a 52-week low of $27.80.
In the last year, PROCEPT BioRobotics(PRCT) shares hit a 52-week high of $89.49 and a 52-week low of $27.80.
Analyst ratings
79%
of 14 ratingsBuy
78.6%
Hold
21.4%
Sell
0%
People also own
Based on the portfolios of people who own PRCT. This list is generated using Robinhood data, and it’s not a recommendation.